1. Home
  2. Analysis
  3. Limbitrol
  4. Vistaril

Limbitrol and Vistaril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Limbitrol and Vistaril. Common interactions include hypoaesthesia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people who take Limbitrol and Vistaril have. It is created by eHealthMe based on reports of 13 people who take Limbitrol and Vistaril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

13 people who take Limbitrol and Vistaril together, and have interactions are studied.

What is Limbitrol?

Limbitrol has active ingredients of amitriptyline hydrochloride; chlordiazepoxide. It is often used in stress and anxiety. eHealthMe is studying from 367 Limbitrol users for its effectiveness, alternative drugs and more.

What is Vistaril?

Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,031 Vistaril users for its effectiveness, alternative drugs and more.

Number of Limbitrol and Vistaril reports submitted per year:

Limbitrol and Vistaril drug interactions.

Common Limbitrol and Vistaril drug interactions by gender *:

female:

  1. Hypoaesthesia
  2. Plantar fasciitis
  3. Rhabdomyolysis
  4. Suicidal ideation
  5. Dependence
  6. Arthralgia
  7. Aseptic necrosis bone
  8. Injection site bruising
  9. Injection site haemorrhage
  10. Injection site pain

male:

  1. Anhedonia
  2. Back pain
  3. Joint swelling
  4. Malaise
  5. Myalgia
  6. Nasal congestion
  7. Neck pain
  8. Pain
  9. Pyrexia
  10. Road traffic accident

Common Limbitrol and Vistaril drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dependence

30-39:

  1. Rhabdomyolysis
  2. Arthralgia
  3. Aseptic necrosis bone
  4. Injection site bruising
  5. Injection site haemorrhage
  6. Injection site pain
  7. Blood creatine phosphokinase increased

40-49:

  1. Hypoaesthesia
  2. Injury
  3. Joint swelling
  4. Malaise
  5. Myalgia
  6. Nasal congestion
  7. Neck pain
  8. Pain
  9. Pyrexia
  10. Road traffic accident

50-59:

n/a

60+:

  1. Syncope

Common conditions people have *:

  1. Migraine (headache): 3 people, 23.08%
  2. Pain: 1 person, 7.69%
  3. Bipolar Disorder (mood disorder): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Limbitrol and Vistaril?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Limbitrol and Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vistaril side effects:

Browse all side effects of Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vistaril interactions:

Browse all interactions between Vistaril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride; chlordiazepoxide and hydroxyzine hydrochloride (the active ingredients of Limbitrol and Vistaril, respectively), and Limbitrol and Vistaril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Limbitrol and Vistaril.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.